Apollomics (APLM) Shares Outstanding (2020 - 2025)
Apollomics (APLM) posted quarterly Shares Outstanding (Entity) of $144.6 million for Q4 2025, up 1292.91% quarter-over-quarter from $10.4 million in Q4 2023.
Apollomics (APLM) Shares Outstanding (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Shares Outstanding (Entity) for 5 consecutive years, with $144.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed N/A year-over-year to $144.6 million; the TTM figure through Dec 2025 stood at $144.6 million (changed N/A YoY), while the FY2025 annual figure was $144.6 million, up 41.76% from the prior year.
- Shares Outstanding (Entity) advanced to $144.6 million in Q4 2025 per APLM's latest filing, from $10.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $144.6 million in Q4 2025 and bottomed at $3.9 million in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $46.3 million across 4 years, with a median of $32.5 million in 2022.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 110.85% in 2023 and fell as far as 80.97% in 2023.
- Apollomics' Shares Outstanding (Entity) stood at $56.4 million in 2021, then dropped by 3.28% to $54.5 million in 2022, then tumbled by 80.97% to $10.4 million in 2023, then soared by 1292.91% to $144.6 million in 2025.
- Business Quant data shows APLM's Shares Outstanding (Entity) at $144.6 million in Q4 2025, $10.4 million in Q4 2023, and $8.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.45 Mn |
| Dec 31, 2023 | 744,110.00 |
| Jun 30, 2023 | 590,000.00 |
| Dec 31, 2022 | 3.91 Mn |
| Jun 30, 2022 | 279,820.00 |
| Dec 31, 2021 | 4.04 Mn |
| Dec 31, 2020 | 3.61 Mn |